Cannabis for dyskinesia in Parkinson disease

@article{Carroll2004CannabisFD,
  title={Cannabis for dyskinesia in Parkinson disease},
  author={C. Carroll and P. Bain and L. Teare and X. Liu and C. Joint and C. Wroath and S. Parkin and P. Fox and D. Wright and J. Hobart and J. Zajicek},
  journal={Neurology},
  year={2004},
  volume={63},
  pages={1245 - 1250}
}
Background: The long-term treatment of Parkinson disease (PD) may be complicated by the development of levodopa-induced dyskinesia. Clinical and animal model data support the view that modulation of cannabinoid function may exert an antidyskinetic effect. The authors conducted a randomized, double-blind, placebo-controlled crossover trial to examine the hypothesis that cannabis may have a beneficial effect on dyskinesia in PD. Methods: A 4-week dose escalation study was performed to assess the… Expand
131 Citations
Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms?
  • 18
Dyskinesia in Parkinson's Disease Therapy
  • 2
  • PDF
Evidence for the use of cannabinoids in Parkinson’s disease
  • 7
Cannabis in the Treatment of Dystonia, Dyskinesias, and Tics
  • 18
  • PDF
Therapy for dyskinesias in Parkinson's disease patients
  • 3
Cannabinoids in the Treatment of Parkinson’s Disease
  • 2
  • PDF
Levodopa-induced dyskinesias in Parkinson's disease.
  • 38
  • PDF
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 34 REFERENCES
Effects of Dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease
  • 289
  • PDF
Unawareness of dyskinesias in Parkinson's and Huntington's diseases
  • 101
Open label evaluation of cannabidiol in dystonic movement disorders.
  • 123
Stimulation of cannabinoid receptors reduces levodopa‐induced dyskinesia in the MPTP‐lesioned nonhuman primate model of Parkinson's disease
  • 156
Utility of an objective dyskinesia rating scale for Parkinson's disease: Inter‐ and intrarater reliability assessment
  • 281
  • PDF
...
1
2
3
4
...